CYTOSINMODIFIKATIONSANALYSE

European patent · EP4211263 · In force

Register entry

Publication number
EP4211263
Application number
EP21791448
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 13, 2021
Published
Jul 19, 2023
Granted
Dec 11, 2024
Protection ends at the latest
Sep 12, 2041
Next annual fee due
Sep 30, 2027
IPC classes
C12Q 1/6806 (2018.01)
Priority
US 202063078181 P 14.09.2020
PCT application
PCT/IB2021/000630 13.09.2021
PCT publication
WO2022/053872 17.03.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 22, 2025

    Change

    Published in Swissreg on 22.10.2025

  3. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. Dec 12, 2024

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 12.12.2024

  5. Dec 11, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.12.2024

Parties

Inventor

SONG, Chunxiao

Oxford, Oxfordshire OX1 2JD, GB

LIU, Yibin

Oxford, Oxfordshire OX1 2JD, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.